Diabetes Drugs Market to Reach US$ 78,261.7 Mn by 2026, Deriving Growth from Increasing Drug Approvals, says Fortune Business Insights Pune, June 26, 2019 (GLOBE NEWSWIRE) -- The global Diabetes Drugs Market derives growth from advancements in drug delivery systems. According to a report published by Fortune Business Insights,...

The huge potential of GLP-1 receptor agonists in the diabetes market opens opportunities for technology providers and pharma companies Stuttgart, Germany, May 7, 2012 (GLOBE NEWSWIRE) -- La Merie Publishing released a new analysis of glucagon-like peptide-1 receptor (GLP-1R) agonists regarding business, commercial, clinical and...